TGFB1 and neoplasm: However, in situ production of IL-2 and IL-15 is necessary to continually reactivate infiltrating NK cells to prevent NK cell exhaustion and inhibition by the tumour milieu suppressor cells and humoral factors, such as TGF-β [5, 6].